Onyx Pharmaceuticals to Present at JPMorgan Healthcare Conference

Onyx Pharmaceuticals to Present at JPMorgan Healthcare Conference 


RICHMOND, Calif., Jan. 8  /PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc. 
today announced that it will present at the 22nd Annual JPMorgan Healthcare
Conference in San Francisco, California, on Thursday, January 15, at 12:30 p.m.
Pacific Time.  Interested parties may access a live webcast of the presentation
at:

http://equityconferences.jpmorgan.com/

It is recommended that listeners log on 15 minutes early in order to register
and download any necessary software.  If you are unable to participate during
the live webcast, a recorded replay of the presentation will be available
shortly after the presentation is completed through February 15.

Onyx Pharmaceuticals is engaged in the development of novel cancer therapies
that target the molecular basis of cancer.  With its partners, the company is
developing small molecule drugs, including BAY 43-9006 with Bayer
Pharmaceuticals Corporation.  For more information about Onyx's pipeline and
activities, visit the company's web site at http://www.onyx-pharm.com/. 

DATASOURCE: Onyx Pharmaceuticals, Inc.



CONTACT:  Julianna Wood of Onyx Pharmaceuticals, Inc., [phone]



Web site:  http://www.onyx-pharm.com/ 

Copyright